Led a global group of quantitative clinical pharmacologists that accelerate and streamline drug development by applying model-informed drug development
approaches in the therapeutic areas respiratory, immunology, central nervous system, cardiovascular and metabolism. Senior group members lead early clinical development teams and are
responsible for delivering overall drug development strategies including biomarker and clinical pharmacology strategies to senior management committees.
Co-led a project how microsegmentation and microtargeting could be leveraged in direct-to-consumer marketing that was sponsored by Human Pharma Leadership
Led development and implementation of global pharmacometrics strategy